United Arab Emirates vs United Kingdom: Access to anti-retroviral drugs, female
United Arab Emirates
97.0%
in 2024
United Kingdom
96.0%
in 2023
United Arab Emirates rank
12th
United Kingdom rank
14th
Access to anti-retroviral drugs, female over time
- United Arab Emirates
- United Kingdom
How they compare
United Arab Emirates currently reports 97.0% against 96.0% in United Kingdom, a difference of 1.0%.
The two have swapped places 2 times across 8 shared years of data; in 2016 it was United Kingdom ahead.
United Arab Emirates ranks 12th and United Kingdom ranks 14th of 141 countries.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | United Arab Emirates | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.5% | 88.0% | 59.5% | United Kingdom |
| 2020s | 82.5% | 90.8% | 8.2% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, United Arab Emirates or United Kingdom?
- United Arab Emirates, at 97.0% against 96.0% in United Kingdom as of 2024.
- What is the difference in access to anti-retroviral drugs, female between United Arab Emirates and United Kingdom?
- 1.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for United Arab Emirates and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do United Arab Emirates and United Kingdom rank globally for access to anti-retroviral drugs, female?
- United Arab Emirates ranks 12th and United Kingdom ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.